• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Carotid Artery Disease Market

    ID: MRFR/MED/4840-CR
    157 Pages
    Kinjoll Dey
    July 2019

    Carotid Artery Disease Market Research Report Information by Diagnosis & Treatment (Carotid Artery Disease and Antihypertensive Drugs), End User (Hospital & Clinics, Ambulatory Surgical Centers and Pharmacies) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Carotid Artery Disease Market Infographic
    Purchase Options

    Carotid Artery Disease Market Summary

    The Global Carotid Artery Disease Market is projected to grow from 12.4 USD Billion in 2024 to 20.7 USD Billion by 2035.

    Key Market Trends & Highlights

    Carotid Artery Disease Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 4.75 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 20.7 USD Billion, indicating robust growth.
    • In 2024, the market is valued at 12.4 USD Billion, reflecting a strong foundation for future expansion.
    • Growing adoption of advanced diagnostic technologies due to increasing prevalence of carotid artery disease is a major market driver.

    Market Size & Forecast

    2024 Market Size 12.4 (USD Billion)
    2035 Market Size 20.7 (USD Billion)
    CAGR (2025-2035) 4.75%

    Major Players

    Medtronic Plc, Pfizer, GE Healthcare, Cardinal Health, Eli Lily and Company, AdvanceCor GmbH, Teleflex, Siemens Healthcare, Daiichi Sankyo Co. Ltd., Abbot Laboratories, Bristol-Myers Squibb, Merck & Cp. Inc., Silk Road Medical, Stryker Corporation, Hitachi, Terumo Corporation, Boston Scientific Corporation, Dickinson Company, L. Gore & Associates, Inc.

    Carotid Artery Disease Market Drivers

    Market Growth Projections

    The Global Carotid Artery Disease Market Industry is projected to experience substantial growth in the coming years. With a market value of 12.4 USD Billion in 2024, it is anticipated to reach 20.7 USD Billion by 2035, reflecting a robust CAGR of 4.75% from 2025 to 2035. This growth trajectory indicates a strong demand for innovative treatment options and improved healthcare services aimed at managing carotid artery disease. The increasing investment in research and development, coupled with advancements in medical technology, is likely to drive this market forward, presenting opportunities for stakeholders in the healthcare sector.

    Growing Geriatric Population

    The aging population is a key driver of the Global Carotid Artery Disease Market Industry. As individuals age, the risk of developing carotid artery disease increases, necessitating effective healthcare solutions. By 2035, the market is expected to reach 20.7 USD Billion, largely due to the growing number of elderly individuals who require medical attention for cardiovascular conditions. This demographic shift is prompting healthcare providers to focus on tailored interventions and preventive strategies for older adults, thereby expanding the market. The implications of this trend are profound, as it highlights the need for specialized care in managing carotid artery disease.

    Rising Awareness and Education

    Increased awareness and education regarding cardiovascular health are pivotal in shaping the Global Carotid Artery Disease Market Industry. Public health campaigns and educational programs are effectively informing individuals about the risks associated with carotid artery disease and the importance of regular check-ups. This heightened awareness is likely to lead to earlier diagnoses and increased demand for treatment options. As healthcare providers emphasize the significance of preventive care, the market is expected to grow in response to these educational efforts. The proactive approach towards health management may ultimately reduce the burden of carotid artery disease on healthcare systems.

    Advancements in Medical Technology

    Technological innovations play a crucial role in shaping the Global Carotid Artery Disease Market Industry. The development of minimally invasive surgical techniques and advanced imaging modalities has revolutionized the diagnosis and treatment of carotid artery disease. For instance, the introduction of carotid artery stenting and improved ultrasound technology has enhanced patient outcomes and reduced recovery times. As these technologies become more widely adopted, they are likely to contribute to market growth. The anticipated CAGR of 4.75% from 2025 to 2035 further underscores the potential for continued advancements in medical technology to drive the industry forward.

    Government Initiatives and Funding

    Government initiatives aimed at improving cardiovascular health are significantly influencing the Global Carotid Artery Disease Market Industry. Various health organizations and government bodies are implementing programs to raise awareness about carotid artery disease and promote preventive measures. Funding for research and development in this field is also increasing, which may lead to the discovery of new treatment options. These initiatives not only enhance public knowledge but also encourage healthcare systems to prioritize the management of carotid artery disease. As a result, the market is likely to benefit from these supportive measures, fostering growth and innovation.

    Increasing Prevalence of Carotid Artery Disease

    The Global Carotid Artery Disease Market Industry is experiencing growth due to the rising prevalence of carotid artery disease, which is often linked to lifestyle factors such as obesity, hypertension, and diabetes. As populations age, the incidence of this condition is expected to rise, leading to an increased demand for diagnostic and therapeutic interventions. In 2024, the market is projected to reach 12.4 USD Billion, reflecting the urgent need for effective management strategies. This trend indicates a growing awareness among healthcare providers and patients alike regarding the importance of early detection and treatment of carotid artery disease.

    Key Companies in the Carotid Artery Disease Market market include

    Industry Developments

      • Boston Scientific Corporation in July 2018, announced the acquisition of Claret Medical Inc.
      • Stryker Corporation in July 2018, renewed the “Pre-Market Approval” (PMA) from the FDA (Food and Drug Administration) of the United States.

    Future Outlook

    Carotid Artery Disease Market Future Outlook

    The Carotid Artery Disease Market is projected to grow at a 4.75% CAGR from 2024 to 2035, driven by technological advancements, increasing prevalence, and enhanced healthcare access.

    New opportunities lie in:

    • Develop innovative minimally invasive surgical techniques to improve patient outcomes.
    • Invest in telemedicine solutions for remote monitoring of carotid artery disease patients.
    • Expand partnerships with healthcare providers to enhance patient education and awareness programs.

    By 2035, the Carotid Artery Disease Market is expected to exhibit robust growth, reflecting advancements in treatment and increased patient engagement.

    Market Segmentation

    By Type

    • Others
    • Magnetic Resonance Imaging
    • Compound Tomography
    • Duplex Ultrasound
    • Diagnosis
    • Treatment
    • Antihypertensive Drugs
    • Cholesterol-Lowering Statins
    • Antiplatelet Drugs
    • Carotid Endarterectomy
    • Carotid Artery Bypass
    • Carotid Artery Angioplasty
    • Ambulatory Surgical Centres                                  
    • Pharmacies
    • Clinics and Hospitals
    • The Middle east Africa
    • Europe
    • Asia-Pacific
    • Latin America
    • North America

    By Region

    • The Middle east Africa
    • Europe
    • Asia-Pacific
    • Latin America
    • North America

    By End-User

    • Ambulatory Surgical Centres                                  
    • Pharmacies
    • Clinics and Hospitals
    • The Middle east Africa
    • Europe
    • Asia-Pacific
    • Latin America
    • North America

    Segmentation

    • Others
    • Magnetic Resonance Imaging
    • Compound Tomography
    • Duplex Ultrasound
    • Diagnosis
    • Treatment
    • Antihypertensive Drugs
    • Cholesterol-Lowering Statins
    • Antiplatelet Drugs
    • Carotid Endarterectomy
    • Carotid Artery Bypass
    • Carotid Artery Angioplasty
    • Ambulatory Surgical Centres                                  
    • Pharmacies
    • Clinics and Hospitals
    • The Middle east Africa
    • Europe
    • Asia-Pacific
    • Latin America
    • North America

    By Medications

    • Antihypertensive Drugs
    • Cholesterol-Lowering Statins
    • Antiplatelet Drugs
    • Carotid Endarterectomy
    • Carotid Artery Bypass
    • Carotid Artery Angioplasty
    • Ambulatory Surgical Centres                                  
    • Pharmacies
    • Clinics and Hospitals
    • The Middle east Africa
    • Europe
    • Asia-Pacific
    • Latin America
    • North America

    Report Overview

    • Recent Development
    • Competitive Analysis
    • Regional Analysis
    • Market Segmentation
    • Value Chain Analysis
    • Dynamics of the Market
    • COVID-19 Analysis
    • Market Overview
    • Historical Period -2019-2020
    • Forecast Period - 2021-2028
    • Base Year -2021
    • Study Period - 2021-2028
    • Others
    • Magnetic Resonance Imaging
    • Compound Tomography
    • Duplex Ultrasound
    • Diagnosis
    • Treatment
    • Antihypertensive Drugs
    • Cholesterol-Lowering Statins
    • Antiplatelet Drugs
    • Carotid Endarterectomy
    • Carotid Artery Bypass
    • Carotid Artery Angioplasty
    • Ambulatory Surgical Centres                                  
    • Pharmacies
    • Clinics and Hospitals
    • The Middle east Africa
    • Europe
    • Asia-Pacific
    • Latin America
    • North America

    Recent Developments

    • Stryker Corporation in July 2018, renewed the “Pre-Market Approval” (PMA) from the FDA (Food and Drug Administration) of the United States.
    • Boston Scientific Corporation in July 2018, announced the acquisition of Claret Medical Inc.
    • Recent Development
    • Competitive Analysis
    • Regional Analysis
    • Market Segmentation
    • Value Chain Analysis
    • Dynamics of the Market
    • COVID-19 Analysis
    • Market Overview
    • Historical Period -2019-2020
    • Forecast Period - 2021-2028
    • Base Year -2021
    • Study Period - 2021-2028
    • Others
    • Magnetic Resonance Imaging
    • Compound Tomography
    • Duplex Ultrasound
    • Diagnosis
    • Treatment
    • Antihypertensive Drugs
    • Cholesterol-Lowering Statins
    • Antiplatelet Drugs
    • Carotid Endarterectomy
    • Carotid Artery Bypass
    • Carotid Artery Angioplasty
    • Ambulatory Surgical Centres                                  
    • Pharmacies
    • Clinics and Hospitals
    • The Middle east Africa
    • Europe
    • Asia-Pacific
    • Latin America
    • North America

    By Surgical Procedures

    • Carotid Endarterectomy
    • Carotid Artery Bypass
    • Carotid Artery Angioplasty
    • Ambulatory Surgical Centres                                  
    • Pharmacies
    • Clinics and Hospitals
    • The Middle east Africa
    • Europe
    • Asia-Pacific
    • Latin America
    • North America

    Report Score and Segmentation

    • Historical Period -2019-2020
    • Forecast Period - 2021-2028
    • Base Year -2021
    • Study Period - 2021-2028
    • Others
    • Magnetic Resonance Imaging
    • Compound Tomography
    • Duplex Ultrasound
    • Diagnosis
    • Treatment
    • Antihypertensive Drugs
    • Cholesterol-Lowering Statins
    • Antiplatelet Drugs
    • Carotid Endarterectomy
    • Carotid Artery Bypass
    • Carotid Artery Angioplasty
    • Ambulatory Surgical Centres                                  
    • Pharmacies
    • Clinics and Hospitals
    • The Middle east Africa
    • Europe
    • Asia-Pacific
    • Latin America
    • North America

    treatment for carotid artery disease

    • Others
    • Magnetic Resonance Imaging
    • Compound Tomography
    • Duplex Ultrasound
    • Diagnosis
    • Treatment
    • Antihypertensive Drugs
    • Cholesterol-Lowering Statins
    • Antiplatelet Drugs
    • Carotid Endarterectomy
    • Carotid Artery Bypass
    • Carotid Artery Angioplasty
    • Ambulatory Surgical Centres                                  
    • Pharmacies
    • Clinics and Hospitals
    • The Middle east Africa
    • Europe
    • Asia-Pacific
    • Latin America
    • North America

    carotid artery disease and stenosis treatment

    • Recent Development
    • Competitive Analysis
    • Regional Analysis
    • Market Segmentation
    • Value Chain Analysis
    • Dynamics of the Market
    • COVID-19 Analysis
    • Market Overview
    • Historical Period -2019-2020
    • Forecast Period - 2021-2028
    • Base Year -2021
    • Study Period - 2021-2028
    • Others
    • Magnetic Resonance Imaging
    • Compound Tomography
    • Duplex Ultrasound
    • Diagnosis
    • Treatment
    • Antihypertensive Drugs
    • Cholesterol-Lowering Statins
    • Antiplatelet Drugs
    • Carotid Endarterectomy
    • Carotid Artery Bypass
    • Carotid Artery Angioplasty
    • Ambulatory Surgical Centres                                  
    • Pharmacies
    • Clinics and Hospitals
    • The Middle east Africa
    • Europe
    • Asia-Pacific
    • Latin America
    • North America

    Carotid Artery Disease Market Competitive Landscape

    • L. Gore & Associates, Inc.
    • Dickinson Company
    • Boston Scientific Corporation
    • Terumo Corporation
    • Hitachi
    • Stryker Corporation
    • Silk Road Medical
    • Merck & Cp. Inc.
    • Bristol-Myers Squibb
    • Abbot Laboratories
    • Daiichi Sankyo Co. Ltd.
    • Teleflex, Siemens Healthcare
    • AdvanceCor GmbH
    • Eli Lily and Company
    • Cardinal Health
    • GE Healthcare
    • Pfizer
    • Medtronic Plc
    • Stryker Corporation in July 2018, renewed the “Pre-Market Approval” (PMA) from the FDA (Food and Drug Administration) of the United States.
    • Boston Scientific Corporation in July 2018, announced the acquisition of Claret Medical Inc.
    • Recent Development
    • Competitive Analysis
    • Regional Analysis
    • Market Segmentation
    • Value Chain Analysis
    • Dynamics of the Market
    • COVID-19 Analysis
    • Market Overview
    • Historical Period -2019-2020
    • Forecast Period - 2021-2028
    • Base Year -2021
    • Study Period - 2021-2028
    • Others
    • Magnetic Resonance Imaging
    • Compound Tomography
    • Duplex Ultrasound
    • Diagnosis
    • Treatment
    • Antihypertensive Drugs
    • Cholesterol-Lowering Statins
    • Antiplatelet Drugs
    • Carotid Endarterectomy
    • Carotid Artery Bypass
    • Carotid Artery Angioplasty
    • Ambulatory Surgical Centres                                  
    • Pharmacies
    • Clinics and Hospitals
    • The Middle east Africa
    • Europe
    • Asia-Pacific
    • Latin America
    • North America

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 11.9 (USD Billion)
    Market Size 2024 12.4 (USD Billion)
    Market Size 2032 17.3 (USD Billion)
    Compound Annual Growth Rate (CAGR) 6.1 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
    Forecast Units Value (USD Billion)
    Segments Covered Type, Application, and End-User
    Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
    Key Vendors Medtronic Plc, Pfizer, GE Healthcare, Cardinal Health, Eli Lilly and Company, AdvanceCor GmbH, Teleflex, Siemens Healthcare, Daiichi Sankyo Co. Ltd., Abbott Laboratories, Bristol-Myers Squibb, Merck & Co. Inc., Silk Road Medical, Stryker Corporation, Hitachi, Terumo Corporation, Boston Scientific Corporation, Dickinson and Company, W. L. Gore & Associates, Inc.
    Key Market Opportunities Increasing government support, rising investments in healthcare, and the presence of a well-established pharmaceutical market
    Key Market Drivers Growing older population, rising cases of life-threatening diseases, and increasing applications of advanced treatment procedures in diagnostics

    Market Highlights

    Author
    Kinjoll Dey
    Research Analyst Level I

    He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

    Leave a Comment

    FAQs

    At what CAGR is the carotid artery disease market projected to grow in the forecast period (2024-2032)?

    Carotid artery disease market projected to grow at approximately 6.10% CAGR during the assessment period (2024-2032).

    How much is the carotid artery disease market worth in the future?

    The valuation of the carotid artery disease market is estimated to increase to USD 17.30 BN by the end of 2032.

    What are the major tailwinds pushing the growth of the global carotid artery disease market?

    Rising prevalence and demand for early diagnosis & treatment of the condition are major tailwinds pushing the growth of the global carotid artery disease market.

    Which region holds the largest share in the global carotid artery disease market?

    North America holds the largest share in the global carotid artery disease market, followed by Europe and the Asia Pacific, respectively.

    Who are the top players in the global carotid artery disease market?

    Becton, Dickinson and Company, Hitachi Ltd., W. L. Gore & Associates, Inc., Terumo Corporation, Abbott, Medtronic, Silk Road Medical, Inc., Stryker Corporation, Boston Scientific Corporation, and Cardinal Health, are some of the top players operating in the global carotid artery disease market.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials